Literature DB >> 18394935

Growth factor contents of autologous human sera prepared by different production methods and their biological effects on chondrocytes.

Yoko Tanaka1, Toru Ogasawara, Yukiyo Asawa, Hisayo Yamaoka, Satoru Nishizawa, Yoshiyuki Mori, Tsuyoshi Takato, Kazuto Hoshi.   

Abstract

To discuss the autologous serum production for cartilage tissue engineering, we compared three kinds of sera: whole blood-derived serum (WBS), platelet-containing plasma-derived serum (PCS), and plasma-derived serum (PDS), on the growth factor contents and their biological effects on human auricular chondrocytes. EGF, VEGF and PDGF levels were highest in WBS, while PCS and PDS followed WBS. The proliferation effects of WBS were the most pronounced, followed by that of PCS, both of which realized a 1000-fold-increase in chondrocyte numbers at the third passage, whereas PDS reached it after passage 4. No significant differences were observed in histology or cartilaginous matrix measurements of tissue-engineered cartilage produced from chondrocytes cultured under different serum conditions. WBS would be clinically useful because of its potent proliferation effects, while PCS, which possibly saves the red cell concentrate, may be an option in cases where there are elevated risks of blood loss.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18394935     DOI: 10.1016/j.cellbi.2007.12.012

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  8 in total

1.  Quantitative investigation of MDA-MB-231 breast cancer cell motility: dependence on epidermal growth factor concentration and its gradient.

Authors:  Tanzila Islam; Haluk Resat
Journal:  Mol Biosyst       Date:  2017-09-26

2.  Zirconium oxide ceramic foam: a promising supporting biomaterial for massive production of glial cell line-derived neurotrophic factor.

Authors:  Zhong-wei Liu; Wen-qiang Li; Jun-kui Wang; Xian-cang Ma; Chen Liang; Peng Liu; Zheng Chu; Yong-hui Dang
Journal:  J Zhejiang Univ Sci B       Date:  2014-12       Impact factor: 3.066

3.  Frequency-modulated pulses of ERK activity transmit quantitative proliferation signals.

Authors:  John G Albeck; Gordon B Mills; Joan S Brugge
Journal:  Mol Cell       Date:  2012-12-06       Impact factor: 17.970

4.  Knockin of mutant PIK3CA activates multiple oncogenic pathways.

Authors:  John P Gustin; Bedri Karakas; Michele B Weiss; Abde M Abukhdeir; Josh Lauring; Joseph P Garay; David Cosgrove; Akina Tamaki; Hiroyuki Konishi; Yuko Konishi; Morassa Mohseni; Grace Wang; D Marc Rosen; Samuel R Denmeade; Michaela J Higgins; Michele I Vitolo; Kurtis E Bachman; Ben Ho Park
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-05       Impact factor: 11.205

5.  Physiological epidermal growth factor concentrations activate high affinity receptors to elicit calcium oscillations.

Authors:  Béatrice Marquèze-Pouey; Sébastien Mailfert; Vincent Rouger; Jean-Marc Goaillard; Didier Marguet
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

6.  Culture Medium Supplements Derived from Human Platelet and Plasma: Cell Commitment and Proliferation Support.

Authors:  Anita Muraglia; Van Thi Nguyen; Marta Nardini; Massimo Mogni; Domenico Coviello; Beatrice Dozin; Paolo Strada; Ilaria Baldelli; Matteo Formica; Ranieri Cancedda; Maddalena Mastrogiacomo
Journal:  Front Bioeng Biotechnol       Date:  2017-11-20

7.  Optimal conditions of collagenase treatment for isolation of articular chondrocytes from aged human tissues.

Authors:  Kazumichi Yonenaga; Satoru Nishizawa; Takumi Nakagawa; Yuko Fujihara; Yukiyo Asawa; Atsuhiko Hikita; Tsuyoshi Takato; Kazuto Hoshi
Journal:  Regen Ther       Date:  2017-01-26       Impact factor: 3.419

8.  Glial Fibrillary Acidic Protein as Biomarker Indicates Purity and Property of Auricular Chondrocytes.

Authors:  Satoru Nishizawa; Sanshiro Kanazawa; Yuko Fujihara; Yukiyo Asawa; Satoru Nagata; Motohiro Harai; Atsuhiko Hikita; Tsuyoshi Takato; Kazuto Hoshi
Journal:  Biores Open Access       Date:  2020-03-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.